2014 Archived Content


Bill Abbott, Vice President, Business Development, Acurian 


Michael Agard, Principal Consultant, Clinical and Regulatory Optimization, Paragon Solutions 


Salvatore Alesci, M.D., Ph.D., Vice President, Scientific Affairs, PhRMA 


Munther Baara, Senior Director, Development Business Technology at Pfizer 


Charles Barr, M.D., Head, Evidence Science & Innovation, Group Medical Director, US Medical Affairs, Genentech, Inc. 


Rhonda Benotti, Business Manager, Strategic Outsourcing, Genentech, Inc. 


Nadia Bracken, Clinical Program Manager, Clinical Operations, Biotie Therapies 


Bonnie Brescia, Founding Principal, BBK Worldwide 


Kyle Brown, CEO, PatientCrossroads 


Jeri Burtchell, Patient Advocate Blogger, Gilenya and Me 


Zhaohui (John) Cai, M.D., Ph.D., Director, Biomedical Informatics, Clinical Medicines Development, AstraZeneca Pharmaceuticals, Inc. 


Hui Cao, M.D., Ph.D., Senior Director, Personalized Healthcare, R&D Information, AstraZeneca 


Katherine Cartwright Norris, Director, Compliance & Integrity Programs, Becker & Associates Consulting; former Director, Corporate Compliance, The Spectranetics Corporation 


Chris Chan, Director, R&D Financial Planning and Analysis, Onyx Pharmaceuticals 


Adam Chasse, COO, RxTrials 


Shailesh Chavan, M.D., Senior Director, Clinical Research, Medical Affairs & Drug Safety, Biotest Pharmaceuticals Corporation 


Janet Christoff, Clinical Trial Manager, Sanofi Pasteur 


Mark A. Collins, Ph.D., Director, Marketing, BioFortis, Inc. 


Larissa Comis-Tis, Director, Clinical Strategy, Thomson Reuters 


Brenda Conger, Founder and Executive Director, CFC International 


Patricia Cornet, Associate Director, Advocacy, Global Recruitment & Analytics, Bristol-Myers Squibb 


Andre Daniels, Ph.D., Executive Medical Director, Global Safety, Amgen 


Nick Darwall-Smith, Vice President, CRS Technology, PAREXEL 


Nancie Deckard, Biomarker CRA, Clinical Operations, Duke Clinical Research Institute (DCRI) 


Carla DeMuro, Head, Patient Reported Outcomes, RTI Health Solutions 


Elizabeth Desrosiers, Director, Global Trial Management, Merck & Co., Inc. 


Reinerio Deza, M.D., Head Global Pharmacovigilance, CDMA Management, Cubist Pharmaceuticals, Inc. 


Kuno Didier van der Post, MSc, Ph.D., Senior Vice President, Business Development, OmniComm Systems, Inc. 


Jessica Dolfi, Senior Business Consultant, Medidata Solutions 


Christopher Dowd, Clinical Research Program Manager, Medical, The Cystic Fibrosis Foundation 


Robert Dracker, M.D., Medical Director, Summerwood Pediatrics; Member, Pediatric Advisory Committee, FDA 


Halleluya Dunn, Clinical Recruitment Manager, Patient & Physician Services, United BioSource Corporation 


Barbara Elashoff, CEO, Patient Profiles, LLC 


Silke Ewald, M.D., Head, Trial Feasibility Assessment, Bayer HealthCare AG 


Jane Fang, Ph.D., R&D IS Lead, Clinical Business Management & Analytics, MedImmune 


Erin Fassett, Clinical Transplant Research Nurse, Baylor Research Institute 


Nikki Fink, Director, Patient Access and Retention Services, PRA International 


Mary Flack, M.D., Vice President, Clinical Research, Nanobio 


Bruno Gagnon, Vice President, Clinical Operations, BioMarin Pharmaceutical, Inc. 


Heidi Gambino, Chief Administrative Director, Surgery, Boston University Medical Center 


Rose Gerber, Director, Communications and Patient Advocacy, Community Oncology Alliance 


Jayne Gershkowitz, Vice President, Patient Advocacy & Public Policy, Amicus Therapeutics, Inc. 


Kenneth Getz, Director, Sponsored Programs, Tufts CSDD; Chairman, CISCRP 


Melynda Geurts, Vice President Operations, DAC Patient Recruitment Services 


Alicia Gilsenan, Ph.D., Senior Director, Epidemiology, RTI Health Solutions 


Abraham Gitterman, Associate, Arnold & Porter, LLP 


Lucas M Glass, Managing Director, Routine Recovery, LLC 


Gretchen Goller, Senior Director, Therapeutic Expertise, Patient Access and Retention Services, PRA International 


Kathleen Greenough, Senior Manager, Clinical Systems & Technology, Biogen Idec 


Bill Gwinn, MBA, Vice President, Clinical Informatics Solutions, Optum 


Kathleen Hanlon, Senior Project Manager, Infinity Pharmaceuticals 


Beth Harper, President, Clinical Performance Partners, Inc. 


Jamie Heywood, Co-Founder and Chairman, PatientsLikeMe 


Bill Hirokawa, Pharm.D., Coordinator, Investigational Drug Section, Pharmaceutical Services, Ronald Reagan UCLA Medical Center 


Toby Ann Holetz, Global Head, Global Aggregate Spend Reporting Team, Quintiles 


Kelly Hollis, MBA, Global Head, Surveys and Observational Studies, RTI Health Solutions 


Kirstin Holzapfel, Deputy Director, Global Clinical Data Center, Bayer / Global Clinical Operations 


Jackie Hoover, Vice President, Account Management, C3i, Inc. 


Ty Hoover, M.D., J.D., FCLM, FCAP, Director, Biorepository Regulatory Support, University of Texas MD Anderson Cancer Center 


Denise Hopkins, Pharm.D., Senior Director, Late Phase Research, Optum 


 Keith Howells, Senior Vice President, Development, OmniComm Systems, Inc 


Michael Howley, Ph.D., Clinical Associate Professor, Business, LeBow College of Business, Drexel University  


Chris Hoyle, Executive Director, Elite Research Network 


Adwoa Hughes-Morley, NIHR Doctoral Research Fellow, MRC North West Hub for Trials Methodology Research, Centre for Primary Care, Institute of Population, The University of Manchester 


Barbara Isquith Arone, MS, Senior Director, Service Operation, Real-World Late Phase, Quintiles 


Michael Jasper, Ph.D., Director, Clinical Documentation, Genzyme, a Sanofi Company 


Les Jebson, Executive Director, Diabetes Center of Excellence, University of Florida Academic Health Center 


Otis Johnson, Executive Director, Clinical Informatics & Feasibility, inVentiv Health, Inc. 


Janet Jones, Vice President, Access to Patients, Synexus Ltd. 


 Michael Jones, Senior Director, Global Site Development, Clinical Operations, Eli Lillly & Co. 


Elke Jordan, Ph.D., Manager, Clinical Development, Bavarian-Nordic GmbH 


Aaron Kamauu, M.D., President & CEO, Anolinx, LLC 


Suresh Kannan, Vice President Products, Clinical Trial Optimization Solutions, IMS Health 


Jeffrey Kasher, Ph.D., Vice President, Global Clinical Trial: Materials, Implementation and Transformation, Eli Lilly & Co.; TransCelerate Operations Committee Member 


Vanessa Kemp, Manager, Project Controls; Master Capital Planning, Engineering, Novartis 


Francis Kendall, Global Head, Statistical Programming and Analysis, GLIDE Future Investigation Team Lead, Genentech 


Jackie Kent, Director, Clinical Development Information & Optimization (CDIO), Eli Lilly & Co. 


Joe Kim, MBA, Director, Clinical Operations, Shire Pharmaceuticals 


Lee King, Vice President, Operations and Strategic Programs, ICON Commercialisation and Outcomes 


Andrea Kirby, Director, Enterprise Integration and Customer Collaboration, Merck & Co, Inc. 


Cathy Koepper, Director, Global Registry Operations, Genzyme, a Sanofi Company 


Debi Koltenuk, Vice President, Products and Services, sampleminded 


Paul Konstant, Manager, Translational Informatics, Janssen Pharmaceutical Co. 


Greg Koski, Ph.D., M.D., Co-Founder & President, ACRES; former Director, Office for Human Research Protections, U.S. Department of Health and Human Services 


Anna Kravets, Director, User Experience Strategy & Realization, Merck & Co., Inc. 


Subha Krishnan, CCDM Principal Data Manager, Optum 


Lisa La Luna, Senior Vice President, Corporate Development & Implementation, ePharmaSolutions 


Andrew Lee, Senior Vice President & Head, Global Clinical Operations, Genzyme Corp., a Sanofi Co. 


Wei Li, Functional Manager, Strategic Outsourcing, Genentech, Inc. 


Craig Lipset, Head, Clinical Innovation, Worldwide Research & Development, Pfizer 


Victor Lobanov, Ph.D., Executive Director, Data Sciences, Informatics, Covance 


Robert Loll, Vice President, Business Development & Strategic Planning, Praxis  


Charles Love, Vice President, Clinical Affairs, Endologix, Inc. 


Sarah Luijpers, Director, Global Recruitment Operations, Forest Research Institute, Inc. 


Jamie MacDonald, CEO, INC 


Marina Malikova, Ph.D., Executive Director, Surgical Translational Research: Operations and Compliance, Surgery, Boston University Medical Center  


Kathleen Mandziuk, MPH, RN, Senior Scientific Affairs Director, PRA Late Phase Services 


Deborah Manzo, Senior Director, Clinical Business Operations & Transformation, Clinical Operations, AbbVie 


Sylvia Marecki, Ph.D., Senior Director, Product Management & Strategy, Product Management, Citeline 


Elizabeth Mascherino, Associate Director, Clinical Operations, Shire Pharmaceuticals 


Jomol Mathew, Ph.D, Director, Clinical and Translational Informatics, IS, Dana-Farber Cancer Institute 


Richard Mayewski, Associate Director, Clinical Trial Intelligence, Novartis 


Juliet McBride, Associate, King & Spalding 


Ruth McHenry, Managing Director, Infinata, Inc. 


Kelly McKee, Associate Director, Clinical Research, Global Trial Optimization, Merck & Co., Inc. 


Kevin McNulty, Director, Product Marketing, Life Sciences, Intralinks, Inc. 


Christopher McSpiritt, Principal Consultant, Clinical and Regulatory Optimization, Paragon Solutions  


Brenda Medina, former Director, Global Head, Clinical Business Operations, Eisai, Inc. 


Kenneth Mark Mills, Director, Clinical Scientific Data Warehouse, Pfizer 


 Liz Moench, President & CEO, MediciGlobal, Inc 


Kim Mooney, Associate Director, Patient Advocacy, Ultragenyx Pharmaceutical Inc. 


Helen Moore, Ph.D., Program Director, Biorepositories & Biospecimen Research Branch Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute 


Eric Morfin, Senior Director, Project Management, Allergan 


Nancy Mulligan, Senior Director, Operations, Patient & Physician Services, UBC 


Meredith Nahm, Ph.D., Associate Director, Clinical Research Informatics, Biomedical Informatics Core, Duke Translational Medicine Institute 


Ramzi Najm, Vice President, R&D Information and Technology Management, Allergan 


Nariman Nasser, Senior Director, Participant Recruitment & Study Management Services, Clinical & Translational Science Institute, University of California, San Francisco 


Nick Neri, Vice President, Product Development, eClinical Insights 


Derenda Nichols, Vice President, Operations Americas, Mapi 


Daniel O’ Connor, InnovoCommerce 


Al O. Pacino II, President, HealthCarePoint.com 


Krista Payne, Executive Director, Value Demonstration within Peri- and Post-Approval Services; Senior Research Scientist, United BioSource Corporation  


Nye Pelton, Clinical Operations Portfolio Manager, Clinical Research, Eli Lilly & Co. 


Gerson Peltz, M.D., Medical Director, Global Pharmacovigilance and Epidemiology, Bristol-Myers Squibb 


Jane Perlmutter, Ph.D., MBA, President and Founder, Gemini Group; Steering Committee Member, Clinical Trials Transformation Initiative (CTTI) 


Christine Pierre, President, The Society for Clinical Research Sites (SCRS) 


Joe Popowicz, Principal Consultant, Emergent Clinical Consulting; former Director, Clinical Operations, Stryker Orthobiologics 


Gary Puckrein, Ph.D., President and Chief Executive Officer, National Minority Quality Forum 


Teresa Raich, Ph.D., Vice President, Nanosphere  


Andrea Renninger, Head, BioBank Operations; Senior Manager, Clinical Coordination, Eisai, Inc. 


Irina Ringler, Director, Feasibility & Clinical Informatics, inVentiv Clinical Trial Recruitment Solutions  


Terry Robins, Consultant; former, Global Director, Scientific Affairs, Quest Diagnostics 


Jorge Rodriguez-Larrain, M.D., Head, Global Site Management, Global Clinical Operations, Alcon 


Stewart Rosen, M.D., Vice President, Medical Affairs, Health Management Solutions, Quintiles 


Jessica Saucier, Clinical Transplant Research Nurse, Baylor Research Institute 


Peggy Schrammel, Vice President & Global Head, Portfolio Management, PACE PAREXEL 


Colin Scott, M.D., Senior Director, Respiratory Development, Clinical Development, Forest Research Institute, Inc. 


Gary Secrest, CTO and Vice Chairman, SAFE-BioPharma Association 


 Edward Seguine, CEO, Clinical Ink  


Lisa Sergas, Manager, Clinical Outsourcing, Medivation 


Nigam Shah, Ph.D., Assistant Professor, Medicine & Biomedical, Informatics, Stanford Center for Biomedical Informatics Research  


Heidi Shea, Director, Vendor & Outsourcing Management, Vertex 


Katheryn Shea, Vice President, BioServices Operations, Precision Bioservices, Inc. 


Mollie Shields-Uehling, President and CEO, SAFE-BioPharma Association 


Eric Silberstein, Co-founder & CEO, TrialNetworks 


Andrew Smith, Global Transparency Reporting Associate Consultant, Eli Lilly and Co. 


Ellie Smith, Global Clinical Site Developer, Alcon 


Tina Soares, Senior Director, Trial Coordination Site Management, GCO, Johnson & Johnson 


Simon Sparkes, Senior Vice President, Clinical, ArisGlobal 


Manfred Stapff, M.D., Executive Director, Global Medical Operations, Forest Laboratories   


Daniel Steenblik, Vice President, Technology and Operations, sampleminded 


Matthew Stumm, Principal, Creative & Media Strategy, BBK Worldwide 


Thomas Sullivan, President, Rockpointe Corporation 


Ramita Tandon, Senior Vice President & General Manager, Patient Outcomes, inVentiv Health, Inc.  


Sameer Tandon, Global Supplier Performance & Innovation (SP&I) Manager, R&D, Outsourcing, Novartis 


Judith Teall, Director, Clinical Excellence, Operations, Exco InTouch 


Piet Theisohn, Director, Resource Management & Business Support, Global Clinical Development, Bayer Healthcare Pharmaceuticals 


Stuart Thiede, Senior Vice-President & General Manager, Global Payment Services, CFS Clinical (CFS) 



 Kate Trainor, Vice President & Global Head, Project Management &Technology, PACE PAREXEL 


Lisa Vaughan, Head, US Clinical Site Management, Alcon 


Rita Viegas, Clinical Operations Lead, Biogen Idec 


Christina Villar, MPH, Director, Clinical Affairs, Johnson & Johnson Vision Care, Inc. 


Lee Walke, Senior Director, Biometrics, Mapi Real World Evidence 


John Walker, Director, NIBR IT, Novartis Institutes for BioMedical Research, Inc. 


Amelia Wall Warner, President, Board of Directors, Gentris Corporation; former, Head Clinical Pharmacogenomics and Clinical Specimen Management, Merck 


Neal Weinreb, M.D., Director, Gaucher Disease - Fabry Disease Treatment Center; University Research Foundation for Lysosomal Storage Diseases 


Chunhua Weng, Ph.D., Florence Irving Assistant Professor of Biomedical Informatics, Columbia University 


Dan White, Vice President, Global Clinical Operations, Quintiles  


Seth Whitelaw, S.J.D., Director, Health Sciences Compliance, Deloitte & Touche LLP  


Adam Wilcox, Ph.D., Director, Medical Informatics, Intermountain Healthcare 


Kenneth A. Wilke, Consultant; former Director, Clinical Pharmacogenomics and Clinical Specimen Management, Merck 


Kevin Williams, Vice President, Corporate Development & Marketing, CFS Clinical (CFS) 


Patty Wood, President, NBIA Disorders Association 


Barbara Wuebbels, Vice President, Patient Advocacy and Medical Affairs, Audentes Therapeutics 


Fei Xue, M.D., Observational Research Director, Center for Observational Research (CfOR), Amgen, Inc. 


Brenda Yanak, Ph.D., Director, Precision Medicine Leader, Clinical Innovation, Pfizer 


Sean Zhao, M.D., Ph.D., former Pharmaceutical Executive in Global Safety Organization 


Anita Zubak, Director, Business Systems Integration, Merck & Co, Inc. 



Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag